Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C

Journal of Medical Virology

Volumn 42, Issue 3, 1994, Pages 299-305

  Hino, Kunihiko ^a   Sainokami, Shigehiko ^a   Shimoda, Kazumi ^a   Iino, Shiro ^b   Wang, Yu ^e   Okamoto, Hiroaki ^c   Miyakawa, Yuzo ^d   Mayumi, Makoto ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Mita Institute   (Japan)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

HCV genotypes; host and viral factors; polymerase chain reaction

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL RESPONSE MODIFIERS; FEMALE; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0028263211     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.1890420318     Document Type: Article

References (36)

1. Hepatitis C virus infection in post‐transfusion hepatitis. An analysis with first‐ and second‐generation assays
2. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non‐A, non‐B hepatitis
3. At least five related, but distinct, hepatitis C viral genotypes exist
4. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
5. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C
6. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B viral hepatitis genome
7. Genetic organization and diversity of the hepatitis C virus
8. Recombinant α‐interferon treatment of non‐A, non‐B (type C) hepatitis: review of studies and recommendations for treatment
9. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
10. A classification of chronic hepatitis
11. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double‐blind, placebo‐controlled trial
12. A pilot study of ribavirin therapy for chronic hepatitis C
13. Non‐A, non‐B hepatitis. I. Recognition, epidemiology, and clinical features
14. The declining risk of post‐transfusion hepatitis C virus infection
15. Lack of protective immunity against reinfection with hepatitis C virus
16. Treatment of chronic non‐A, non‐B hepatitis with recombinant human alpha interferon. A preliminary report
17. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease
18. Randomised controlled trial of interferon alpha (lymphoblastoid interferon) in chronic non‐A, non‐B hepatitis
19. Pilot study of recombinant human a‐interferon for chronic non‐A, non‐B hepatitis
20. Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction (1992)
21. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis
22. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution
23. A new type of hepatitis C virus in patients in Thailand
24. Detection of hepatitis C virus RNA by a two‐stage poly‐merase chain reaction with two pairs of primers deduced from the 5′‐noncoding region
25. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions
26. Full‐length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes
27. Genetic drift of hepatitis C virus during an 8.2‐year infection in a chimpanzee: variability and stability
28. Typing hepatitis C virus by polymerase chain reaction with type‐specific primers: application to clinical surveys and tracing infectious sources
29. Ribavirin treatment for chronic hepatitis C
30. Decrease in serum hepatitis C viral RNA during alpha‐interferon therapy for chronic hepatitis C
31. Sequence variability in the 5′ non‐coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity
32. Clinical backgrounds of the patients having different types of hepatitis C virus genomes
33. Structure and organization of the hepatitis C virus genome isolated from human carriers
34. Interferon for non‐A, non‐B chronic hepatitis. A meta‐analysis of randomised clinical trials
35. Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐ct therapy: relationship to genotypes of hepatitis C virus